TY - JOUR
T1 - Circadian clocks and insulin resistance
AU - Stenvers, Dirk Jan
AU - Scheer, Frank A. J. L.
AU - Schrauwen, Patrick
AU - la Fleur, Susanne E.
AU - Kalsbeek, Andries
N1 - Funding Information:
F.A.J.L.S. received speaker fees from Bayer Healthcare, Kellogg Company, Philips, Pfizer, Sentara Healthcare and Vanda Pharmaceuticals. F.A.J.L.S. was supported in part by NIH grants R01DK099512, R01HL118601, R01DK102696, R01DK105072 and R01HL140574. The other authors declare no competing interests.
Publisher Copyright:
© 2018, Springer Nature Limited.
PY - 2019/2
Y1 - 2019/2
N2 - Insulin resistance is a main determinant in the development of type 2 diabetes mellitus and a major cause of morbidity and mortality. The circadian timing system consists of a central brain clock in the hypothalamic suprachiasmatic nucleus and various peripheral tissue clocks. The circadian timing system is responsible for the coordination of many daily processes, including the daily rhythm in human glucose metabolism. The central clock regulates food intake, energy expenditure and whole-body insulin sensitivity, and these actions are further fine-tuned by local peripheral clocks. For instance, the peripheral clock in the gut regulates glucose absorption, peripheral clocks in muscle, adipose tissue and liver regulate local insulin sensitivity, and the peripheral clock in the pancreas regulates insulin secretion. Misalignment between different components of the circadian timing system and daily rhythms of sleep-wake behaviour or food intake as a result of genetic, environmental or behavioural factors might be an important contributor to the development of insulin resistance. Specifically, clock gene mutations, exposure to artificial light-dark cycles, disturbed sleep, shift work and social jet lag are factors that might contribute to circadian disruption. Here, we review the physiological links between circadian clocks, glucose metabolism and insulin sensitivity, and present current evidence for a relationship between circadian disruption and insulin resistance. We conclude by proposing several strategies that aim to use chronobiological knowledge to improve human metabolic health.
AB - Insulin resistance is a main determinant in the development of type 2 diabetes mellitus and a major cause of morbidity and mortality. The circadian timing system consists of a central brain clock in the hypothalamic suprachiasmatic nucleus and various peripheral tissue clocks. The circadian timing system is responsible for the coordination of many daily processes, including the daily rhythm in human glucose metabolism. The central clock regulates food intake, energy expenditure and whole-body insulin sensitivity, and these actions are further fine-tuned by local peripheral clocks. For instance, the peripheral clock in the gut regulates glucose absorption, peripheral clocks in muscle, adipose tissue and liver regulate local insulin sensitivity, and the peripheral clock in the pancreas regulates insulin secretion. Misalignment between different components of the circadian timing system and daily rhythms of sleep-wake behaviour or food intake as a result of genetic, environmental or behavioural factors might be an important contributor to the development of insulin resistance. Specifically, clock gene mutations, exposure to artificial light-dark cycles, disturbed sleep, shift work and social jet lag are factors that might contribute to circadian disruption. Here, we review the physiological links between circadian clocks, glucose metabolism and insulin sensitivity, and present current evidence for a relationship between circadian disruption and insulin resistance. We conclude by proposing several strategies that aim to use chronobiological knowledge to improve human metabolic health.
KW - URINARY MELATONIN EXCRETION
KW - RANDOMIZED CONTROLLED-TRIAL
KW - IMPAIRS GLUCOSE-TOLERANCE
KW - PARTIAL SLEEP-DEPRIVATION
KW - FASTING LIPID PROFILES
KW - HUMAN ADIPOSE-TISSUE
KW - SLOW-WAVE SLEEP
KW - HIGH-FAT DIET
KW - SUPRACHIASMATIC NUCLEUS
KW - DIURNAL-VARIATION
U2 - 10.1038/s41574-018-0122-1
DO - 10.1038/s41574-018-0122-1
M3 - (Systematic) Review article
SN - 1759-5029
VL - 15
SP - 75
EP - 89
JO - Nature Reviews Endocrinology
JF - Nature Reviews Endocrinology
IS - 2
ER -